Skip to main content

Market Overview

30 Stocks Moving In Monday's Mid-Day Session



  • Yield10 Bioscience Inc (NASDAQ: YTEN) shares gained 280 percent to $7.41 after the company reported granting of research license to Monsanto for evaluation of 2 novel yield traits in soybean.
  • ARGENX SE/S ADR (NASDAQ: ARGX) shares jumped 55 percent to $47.19 after the company reported positive topline results from Phase 2 proof-of-concept trial of ARGX-113 in generalized myasthenia gravis.
  • Net Element Inc (NASDAQ: NETE) shares climbed 52.1 percent to $6.13.
  • Shineco Inc (NASDAQ: TYHT) shares rose 23.3 percent to $3.23 after the company disclosed a Share Exchange and Acquisition deal with Western Xinjiang Tiansheng Agricultural Development Co.
  • Riot Blockchain Inc (NASDAQ: RIOT) shares jumped 19.6 percent to $18.98 after gaining 8.63 percent on Friday.
  • bluebird bio Inc (NASDAQ: BLUE) shares gained 18.9 percent to $203.49 after the company announced updated clinical results from ongoing Phase 1 multicenter study of LentiGlobin gene therapy in severe sickle cell disease at the ASH2017.
  • Famous Dave's of America, Inc. (NASDAQ: PLAY) shares rose 18.9 percent to $6.30.
  • Inc (NASDAQ: OSTK) surged 17.7 percent to $53.05 following 13G filing from Morgan Stanley late Friday showing increased stake from 130,000 shares to 2.87 million shares.
  • Blueprint Medicines Corp (NASDAQ: BPMC) surged 17 percent to $84.07 after the company announced new data from ongoing Phase 1 clinical trial of Avapritinib.
  • Seven Stars Cloud Group Inc (NASDAQ: SSC) jumped 14.7 percent to $2.81.
  • SunPower Corporation (NASDAQ: SPWR) climbed 14.5 percent to $9.55. Baird upgraded SunPower from Neutral to Outperform.
  • Clearside BioMedical, Inc. (NASDAQ: CLSD) gained 13.6 percent to $6.6933.
  • Intersect ENT Inc (NASDAQ: XENT) shares rose 13.1 percent to $32.35 as the company reported the FDA approval of SINUVA Sinus Implant as a treatment option for recurrent nasal polyps.
  • CHF Solutions Inc (NASDAQ: CHFS) shares gained 12.8 percent to $3.87 after climbing 11.00 percent on Friday.
  • U.S. Global Investors, Inc. (NASDAQ: GROW) shares rose 12.2 percent to $4.43.
  • Helios and Matheson Analytics Inc (NASDAQ: HMNY) climbed 10.4 percent to $9.33 following news of a new marketing and performance-based sales deal with a movie distributor.
  • Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) gained 8.5 percent to $2.69. Wells Fargo upgraded Sunesis Pharmaceuticals from Market Perform to Outperform.
  • Marathon Patent Group Inc (NASDAQ: MARA) gained 8.2 percent to $4.77 after declining 3.71 percent on Friday.
  • Catalyst Biosciences Inc (NASDAQ: CBIO) climbed 7.7 percent to $8.12 as the company announced promising interim Phase 1/2 CB 2679D/ISU304 results at the ASH2017.
  • Trade Desk Inc (NASDAQ: TTD) rose 7.5 percent to $48.64. SunTrust Robinson Humphrey upgraded Trade Desk from Hold to Buy.


  • Spark Therapeutics Inc (NASDAQ: ONCE) shares dipped 42.1 percent to $42.50 on volatile factor VIII activity data in hemophilia A gene therapy.
  • Syros Pharmaceuticals Inc (NASDAQ: SYRS) tumbled 37.3 percent to $7.76 following presentation at the ASH 2017 on Phase 2 trial of SY-1425 in genomically defined AML and MDS patients.
  • Athenex Inc (NASDAQ: ATNX) shares dropped 16.3 percent to $13.37.
  • Juno Therapeutics Inc (NASDAQ: JUNO) dipped 12.2 percent to $51.49. Juno Therapeutics and Celgene released additional data from the TRANSCEND trial of JCAR017 in patients with relapsed or refractory aggressive B-cell non-hodgkin lymphoma.
  • Anavex Life Sciences Corp (NASDAQ: AVXL) shares declined 11.7 percent to $3.26. Anavex Life Sciences reported FY17 loss of $0.33 per share, versus a year-ago loss of $0.42 per share.
  • Trillium Therapeutics Inc (NASDAQ: TRIL) shares fell 9.8 percent to $10.15
  • Verastem Inc (NASDAQ: VSTM) shares declined 8.5 percent to $3.96 after the company announced clinical data from the pivotal Phase 3 DUO study.
  • Global Blood Therapeutics Inc (NASDAQ: GBT) dropped 8.5 percent to $41.88 after the company released results from multiple data presentations during the 59th American Society of Hematology Annual Meeting & Exposition.
  • Intevac, Inc. (NASDAQ: IVAC) shares dropped 8.1 percent to $6.30 after gaining 0.74 percent on Friday.
  • Seattle Genetics, Inc. (NASDAQ: SGEN) shares fell 7 percent to $55.11. Seattle Genetics highlighted five-year survival results from Phase 1 trial of ADCETRIS in frontline mature T-cell lymphoma at the ASH 2017.

Related Articles (ARGX + ATNX)

View Comments and Join the Discussion!

Posted-In: Mid-Day Losers Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at